Related references
Note: Only part of the references are listed.Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide
R. J. Young et al.
BRITISH JOURNAL OF CANCER (2012)
MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3
Bing Feng et al.
CANCER (2012)
Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
Vesselina G. Cooke et al.
CANCER CELL (2012)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
Hai T. Tran et al.
LANCET ONCOLOGY (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
miR-200b Targets Ets-1 and Is Down-regulated by Hypoxia to Induce Angiogenic Response of Endothelial Cells
Yuk Cheung Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
Sergio Marchini et al.
LANCET ONCOLOGY (2011)
Regulation of vascular endothelial growth factor signaling by miR-200b
Young-Chul Choi et al.
MOLECULES AND CELLS (2011)
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
Manav Korpal et al.
NATURE MEDICINE (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
RNA interference in the clinic: challenges and future directions
Chad V. Pecot et al.
NATURE REVIEWS CANCER (2011)
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
Balazs Gyoerffy et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non-Small Cell Lung Cancer after Surgical Resection
Santosh K. Patnaik et al.
CANCER RESEARCH (2010)
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
Hee Dong Han et al.
CLINICAL CANCER RESEARCH (2010)
Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non-Small-Cell Lung Cancer
Emer O. Hanrahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
Paolo Ceppi et al.
MOLECULAR CANCER RESEARCH (2010)
Loss of miR-200 Inhibition of Suz12 Leads to Polycomb-Mediated Repression Required for the Formation and Maintenance of Cancer Stem Cells
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
mir-200c Regulates Induction of Apoptosis through CD95 by Targeting FAP-1
Robert Schickel et al.
MOLECULAR CELL (2010)
Use of Data-Biased Random Walks on Graphs for the Retrieval of Context-Specific Networks from Genomic Data
Kakajan Komurov et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
Dawn R. Cochrane et al.
JOURNAL OF ONCOLOGY (2010)
Tumor Self-Seeding by Circulating Cancer Cells
Mi-Young Kim et al.
CELL (2009)
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Yohei Shimono et al.
CELL (2009)
miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
Liana Adam et al.
CLINICAL CANCER RESEARCH (2009)
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
Don L. Gibbons et al.
GENES & DEVELOPMENT (2009)
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
Xiaoxia Hu et al.
GYNECOLOGIC ONCOLOGY (2009)
miR-200 Enhances Mouse Breast Cancer Cell Colonization to Form Distant Metastases
Derek M. Dykxhoorn et al.
PLOS ONE (2009)
MicroRNAs as regulators of epithelial-mesenchymal transition
Philip. A. Gregory et al.
CELL CYCLE (2008)
MicroRNA expression profiles in serous ovarian carcinoma
Eun Ji Nam et al.
CLINICAL CANCER RESEARCH (2008)
Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics
Judy R. van Beijnum et al.
EXPERIMENTAL CELL RESEARCH (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3
Pasquale Fasanaro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M. Merritt et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis
Manav Korpal et al.
RNA BIOLOGY (2008)
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Premal H. Thaker et al.
NATURE MEDICINE (2006)
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery
CN Landen et al.
CANCER RESEARCH (2005)
Share Paper
